Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNYNF crawled time : 13:00 save search
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 1.83%
C: 0.89%
miss
IGM Biosciences Announces Refocusing of Sanofi Collaboration
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: -13.23%
collaboration sanofi
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
label children astrazeneca
Sanofi Agrees to Settle 4,000 Zantac Cancer Lawsuits in US State Courts
Published: 2024-04-04 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
state cancer sanofi
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-29 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
ADAG | $2.63 -0.38% -0.38% 5.4K
|
Manufacturing
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
year update financial results
Exscientia Business and Financial Update for the Full Year 2023
Published: 2024-03-21 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
EXAI | $4.24 -2.75% -2.83% 370K
|
|
| O: -3.35%
H: 0.0%
C: -7.39%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
business year update financial
Constellation Appoints New Chief Financial Officer, Daniel Bisgeier
Published: 2024-03-14 (Crawled : 13:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
financial
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
business year therapeutics financial results
BioVaxys Announces Allowance of DPX-Related Patent for Japan and Filing of Additional International Patent Applications
Published: 2024-03-05 (Crawled : 13:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
patent japan international
Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: -3.69%
H: 4.0%
C: -0.58%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
tnx-1500 pharmaceuticals preclinical
MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024
Published: 2024-03-04 (Crawled : 13:00) - globenewswire.com
MLTX | $42.19 -0.14% -0.14% 530K
|
|
| O: 0.51%
H: 0.86%
C: -4.53%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
nanobody meeting trial
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10
Published: 2024-02-29 (Crawled : 13:00) - globenewswire.com
MLTX | $42.19 -0.14% -0.14% 530K
|
|
| O: 1.3%
H: 0.0%
C: -16.18%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
day business year financial
Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 3.26%
H: 2.37%
C: -1.53%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
tnx-1500 pharmaceuticals trial
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: 18.06%
H: 17.95%
C: 17.1%
business year therapeutics financial results
MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the Nanobody® sonelokimab (SLK) in Hidradenitis Suppurativa (HS)
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
MLTX | $42.19 -0.14% -0.14% 530K
|
|
| O: 0.0%
H: 2.86%
C: 0.13%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.82%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
nanobody fda positive ema program
Sanofi, Denali ALS Candidate Flops in Mid-Stage Trial
Published: 2024-02-19 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
candidate als trial
Press Release: Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS
Published: 2024-02-15 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.16%
H: 1.48%
C: 0.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
potential therapy show
Areteia Therapeutics Announces Appointment of Daniel Becker, M.D., Ph.D. To Board of Directors
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.16%
H: 1.48%
C: 0.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
therapeutics
Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer
Published: 2024-02-07 (Crawled : 13:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
financial
Resalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officer
Published: 2024-02-01 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -4.37%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
medical therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.